Stifel Nicolaus Lowers Revolution Medicines (NASDAQ:RVMD) Price Target to $78.00
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price decreased by investment analysts at Stifel Nicolaus from $80.00 to $78.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 91.46% from the stock’s previous […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price decreased by investment analysts at Stifel Nicolaus from $80.00 to $78.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 91.46% from the stock’s previous […]
